Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Study examines the role of spirituality in health, well-being of breast cancer survivors

Throughout her 20-year career as a nurse practitioner, Jennifer Hulett noticed survivors of breast cancer would often express gratitude for being alive and mention God or a divine acknowledgement that had improved their health and well-being.

23 Jun 2021

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.

23 Jun 2021

Study: Subconscious changes in day-to-day movements can predict Alzheimer’s disease

As people go about their daily activities, complex fluctuations in their movement occur without conscious thought. These fluctuations -- known as fractal motor activity regulation (FMAR) -- and their changes are not readily detectable to the naked eye, but FMAR patterns can be recorded using a wristwatch-like device known as an actigraph.

23 Jun 2021

Combination of biological markers could improve triage and risk prediction in dengue patients

Researchers have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease, according to a study published today in eLife.

22 Jun 2021

Investigational Alzheimer's drug reduces molecular markers of the disease

An investigational Alzheimer's drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of Medicine in St. Louis through its Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU).

21 Jun 2021

A World First: sequencing polyclonal antibodies using only proteomics

News-Medical speaks to Bin Ma, President of Rapid Novor, about their latest research that sequenced polyclonal antibodies using only proteomics.

From Rapid Novor Inc 21 Jun 2021

Can a prior rhinovirus infection protect against COVID-19?

Researchers at the Yale School of Medicine found that rhinovirus accelerates interferon-stimulated genes.

21 Jun 2021

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response (pCR), according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.

18 Jun 2021

New platform can detect microRNA-205 with high sensitivity, excellent selectivity

In a paper published in NANO, a team of researchers from Jiangnan University, China have prepared a convenient sensing platform which can detect microRNA-205 (MiR-205) with high sensitivity and excellent selectivity using TpTta-COF nanosheet and fluorescent oligonucleotide probes.

18 Jun 2021

PET/CT images can be used to measure biomarker levels, predict lung cancer outcomes

Tests that analyze biomarkers are used during cancer management to guide treatment and provide information about patient prognosis.

17 Jun 2021

How the common cold can provide protection against COVID-19

In a recent study, researchers found that prior infection with the rhinovirus can provide a more effective immune response against SARS-CoV-2 infection.

17 Jun 2021

New noninvasive biomarker can be used in the diagnosis of NAFLD

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver failure or cancer. Currently, nonalcoholic steatohepatitis (NASH) diagnosis requires an invasive liver biopsy which can lead to procedural complications.

17 Jun 2021

MicroRNAs in urine could be a promising biomarker to diagnose brain tumors, study reveals

A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors.

17 Jun 2021

Positron emission tomography can accurately measure effects of COVID-19 on the brain

The effects of COVID-19 on the brain can be accurately measured with positron emission tomography (PET), according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting.

17 Jun 2021

Could urine tests predict kidney injury and mortality in COVID-19?

A team of scientists from the Columbia University, New York, has recently identified a potential biomarker to predict acute kidney injury in COVID-19 patients. By analyzing urine samples of 444 COVID-19 patients, they have revealed that the urinary level of neutrophil gelatinase-associated lipocalin (NGAL) can be used to determine the severity and duration of acute kidney and tubular injuries, as well as to predict the risk of mortality in acute COVID-19 patients.

15 Jun 2021

Novel biomarker effectively detects Alzheimer's disease before symptoms emerge

A newly developed radiotracer can measure increases in brain tau at least a year prior to the emergence of other symptoms.

15 Jun 2021

Plasma zinc status not an effective prognostic factor for hospitalized COVID-19 patients

Due to previous evidence suggesting that zinc deficiencies can lead to complications along with an impaired antiviral response, a group of international researchers has undertaken a prospective observational study to investigate this association further.

14 Jun 2021

Artificial intelligence for predicting TMB-H colorectal cancer from histopathological characteristics

Biomarkers are important determinants of appropriate and effective therapeutic approaches for various diseases including cancer.

14 Jun 2021

PET radiotracer can noninvasively identify and monitor pulmonary fibrosis

Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

13 Jun 2021

Deep neural network model can accurately predict the brain age of healthy patients

A study shows that a deep neural network model can accurately predict the brain age of healthy patients based on electroencephalogram data recorded during an overnight sleep study, and EEG-predicted brain age indices display unique characteristics within populations with different diseases.

10 Jun 2021

Biomarker News and Research

Further Reading

Study examines the role of spirituality in health, well-being of breast cancer survivors

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

Study: Subconscious changes in day-to-day movements can predict Alzheimer’s disease

Combination of biological markers could improve triage and risk prediction in dengue patients

Investigational Alzheimer's drug reduces molecular markers of the disease

A World First: sequencing polyclonal antibodies using only proteomics

Can a prior rhinovirus infection protect against COVID-19?

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

New platform can detect microRNA-205 with high sensitivity, excellent selectivity

PET/CT images can be used to measure biomarker levels, predict lung cancer outcomes

How the common cold can provide protection against COVID-19

New noninvasive biomarker can be used in the diagnosis of NAFLD

MicroRNAs in urine could be a promising biomarker to diagnose brain tumors, study reveals

Positron emission tomography can accurately measure effects of COVID-19 on the brain

Could urine tests predict kidney injury and mortality in COVID-19?

Novel biomarker effectively detects Alzheimer's disease before symptoms emerge

Plasma zinc status not an effective prognostic factor for hospitalized COVID-19 patients

Artificial intelligence for predicting TMB-H colorectal cancer from histopathological characteristics

PET radiotracer can noninvasively identify and monitor pulmonary fibrosis

Deep neural network model can accurately predict the brain age of healthy patients

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo